SMARCA4 and colonic neoplasm: In this study, we performed immunostaining of BRG1 on commercial colon cancer tissue microarray (TMA, n = 75) and our custom TMA (n = 191), and then explored the relationship between BRG1 protein expression and clinicopathological features of colon cancer.